1. Home
  2. CTRE vs BIO Comparison

CTRE vs BIO Comparison

Compare CTRE & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

HOLD

Current Price

$39.05

Market Cap

9.9B

Sector

Real Estate

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$387.11

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRE
BIO
Founded
2013
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.0B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
CTRE
BIO
Price
$39.05
$387.11
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
$42.40
$339.75
AVG Volume (30 Days)
1.8M
251.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
3.44%
N/A
EPS Growth
96.25
142.61
EPS
0.74
N/A
Revenue
$476,393,000.00
$2,583,200,000.00
Revenue This Year
$5.97
$2.74
Revenue Next Year
$13.39
$3.20
P/E Ratio
$53.19
N/A
Revenue Growth
60.79
0.65
52 Week Low
$32.79
$236.73
52 Week High
$43.62
$396.23

Technical Indicators

Market Signals
Indicator
CTRE
BIO
Relative Strength Index (RSI) 42.48 75.57
Support Level $38.28 $289.16
Resistance Level $40.12 N/A
Average True Range (ATR) 0.78 11.00
MACD -0.00 1.25
Stochastic Oscillator 55.06 79.98

Price Performance

Historical Comparison
CTRE
BIO

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: